Signifor LAR Interactions
There are 398 drugs known to interact with Signifor LAR (pasireotide), along with 6 disease interactions. Of the total drug interactions, 209 are major, 181 are moderate, and 8 are minor.
- View all 398 medications that may interact with Signifor LAR
- View Signifor LAR disease interactions (6)
Most frequently checked interactions
View interaction reports for Signifor LAR (pasireotide) and the medicines listed below.
- Abilify MyCite (aripiprazole)
- Actemra (tocilizumab)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adempas (riociguat)
- Adriamycin (doxorubicin)
- Advair Diskus (fluticasone / salmeterol)
- Afinitor Disperz (everolimus)
- Afstyla (antihemophilic factor)
- Aggrenox (aspirin / dipyridamole)
- Akynzeo (netupitant / palonosetron)
- Aldurazyme (laronidase)
- Alimta (pemetrexed)
- Alprazolam Intensol (alprazolam)
- Amicar (aminocaproic acid)
- amoxicillin
- Apresazide (hydralazine / hydrochlorothiazide)
- Aptivus (tipranavir)
- Arava (leflunomide)
- Aricept (donepezil)
- Arzerra (ofatumumab)
- Asendin (amoxapine)
- Atarax (hydroxyzine)
- ATNAA (atropine / pralidoxime)
- Atripla (efavirenz / emtricitabine / tenofovir disoproxil)
- Atrovent (ipratropium)
- Aubagio (teriflunomide)
- Corlanor (ivabradine)
- Eloctate (antihemophilic factor)
- Hizentra (immune globulin subcutaneous)
Signifor LAR disease interactions
There are 6 disease interactions with Signifor LAR (pasireotide) which include:
Report options
QR code containing a link to this page
More about Signifor LAR (pasireotide)
- Signifor LAR consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: somatostatin and somatostatin analogs
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.